TAK1 mRNA Expression in the Tumor Tissue of Locally Advanced Head and Neck Cancer Patients
Resistance to radio and chemotherapy is one of the major drawbacks in the progression of head and neck squamous cell cancer (HNSCC) patients, evidencing the importance of finding optimum molecular prognosis markers to develop personalized treatment schedules. TGF-β effector TAK1 activity has been re...
| Príomhchruthaitheoirí: | , , , , |
|---|---|
| Formáid: | info:eu-repo/semantics/article |
| Teanga: | eng |
| Foilsithe / Cruthaithe: |
Libertas Academica
2012
|
| Ábhair: | |
| Rochtain ar líne: | https://hdl.handle.net/10171/23495 |